This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction. What Makes an Antipsychotic Atypical?

Stephen M. Stahl, MD, PhD

Published: October 1, 1999

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The term atypical antipsychotic has caused a good deal of debate and confusion, because its meaning has evolved over time, and those with different perspectives on this issue tend to define this term differently.1 To a pharmacologist, it can mean "serotonin-2A (5-HT2A)-dopamine-2 (D2) antagonist" or "multiple simultaneous neurotransmitter binding activities." To a prescriber, it can mean "low extrapyramidal symptoms" or "reduction of negative symptoms."’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Neurologic and Neurocognitive , Neurology

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...